(Q33766974)

English

Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

object named as

Emilio Bria

2

0 references

Isabella Sperduti

object named as

Isabella Sperduti

8

0 references

Diana Giannarelli

object named as

Diana Giannarelli

3

0 references

author name string

Federica Cuppone

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Vanja Vaccaro

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Michele Milella

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Cecilia Nisticò

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Enzo Maria Ruggeri

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sergio Bracarda

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Paola Pinnarò

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gaetano Lanzetta

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Paola Muti

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Francesco Cognetti

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Paolo Carlini

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

9 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

675

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

NCCN clinical practice guidelines in oncology: prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Empirical vs natural weighting in random effects meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Meta-analyses of randomised clinical trials in oncology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Confidence intervals for the number needed to treat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

22 June 2018

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Interpreting Measures of Treatment Effect in Cancer Clinical Trials

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- versus 8-month randomized trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-675

21 January 2018

A Randomized Trial (Irish Clinical Oncology Research Group 97-01) Comparing Short Versus Protracted Neoadjuvant Hormonal Therapy Before Radiotherapy for Localized Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016294

30 October 2018

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 2010 NCCN clinical practice guidelines in oncology on prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2-T3 prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21143897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-675

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33766974&oldid=2195761765"